Hyperfibrinolysis

Hyperfibrinolysis (pronounced: hi-per-fi-brin-o-ly-sis) is a medical condition characterized by an increased rate of fibrinolysis, the process that leads to the breakdown of blood clots.

Etymology

The term "Hyperfibrinolysis" is derived from the Greek words "hyper" meaning over or excessive, "fibrin" referring to a protein involved in blood clotting, and "lysis" meaning dissolution or destruction.

Definition

Hyperfibrinolysis is a condition in which the body's natural process of breaking down blood clots, known as fibrinolysis, is overly active. This can lead to excessive bleeding, as clots that would normally stop bleeding are broken down too quickly.

Causes

Hyperfibrinolysis can be caused by a variety of factors, including certain medications, liver disease, and certain types of cancer. It can also be a complication of major surgery or trauma.

Symptoms

Symptoms of hyperfibrinolysis can include prolonged bleeding, easy bruising, and in severe cases, life-threatening hemorrhage.

Diagnosis

Diagnosis of hyperfibrinolysis is typically made through blood tests that measure the levels of certain clotting factors and breakdown products in the blood.

Treatment

Treatment for hyperfibrinolysis typically involves addressing the underlying cause of the condition. This may include discontinuing certain medications, treating underlying diseases, or in some cases, administering medications to slow the rate of fibrinolysis.

Related Terms

• Fibrinolysis
• Blood clot
• Hemorrhage
• Coagulation
• Antifibrinolytic

External links

• Medical encyclopedia article on Hyperfibrinolysis
• Wikipedia's article - Hyperfibrinolysis

This WikiMD dictionary article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski